The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2026

Filed:

Mar. 18, 2024
Applicant:

Asha Medical, Inc., San Ramon, CA (US);

Inventor:

Vivek K. Sharma, San Ramon, CA (US);

Assignee:

ASHA MEDICAL, INC., San Ramon, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 2/02 (2006.01); A61J 1/20 (2006.01); A61K 45/06 (2006.01); A61M 5/19 (2006.01); A61M 39/14 (2006.01); A61M 39/24 (2006.01); A61N 2/00 (2006.01); A61N 2/06 (2006.01); A61B 5/055 (2006.01); A61B 6/03 (2006.01); A61B 6/50 (2024.01);
U.S. Cl.
CPC ...
A61N 2/004 (2013.01); A61J 1/2006 (2015.05); A61J 1/2037 (2015.05); A61J 1/2072 (2015.05); A61K 45/06 (2013.01); A61M 5/19 (2013.01); A61M 39/14 (2013.01); A61M 39/24 (2013.01); A61N 2/002 (2013.01); A61N 2/02 (2013.01); A61B 5/055 (2013.01); A61B 6/032 (2013.01); A61B 6/037 (2013.01); A61B 6/50 (2013.01); A61N 2/06 (2013.01);
Abstract

Systems and methods for destroying or inhibiting cancer cells and other rapidly-dividing cells including an alternating polarity (AP) magnetic field generator and one or more AP electromagnetic coil adapted to be coupled to at least a portion of a patient's body, and a controller to control the AP magnetic field generator and at least one AP electromagnetic coil and cause the field generator and coil to apply AP magnetic field having a frequency of 0.5-500 KHz and a field strength of 0.5-5 mT to the at least a portion of the patient's body area to achieve a desired inhibiting effect on cancer cells or other rapidly-dividing cells. Treatments provided by the system may be co-administered with an anti-cancer therapy such as a chemotherapy drug, a hormone therapy drug, targeted therapy drugs, immunotherapy drugs, an angiogenesis inhibitor drug, or tumor treatment field therapy.


Find Patent Forward Citations

Loading…